Riproximin Exhibits Diversity in Sugar Binding, and Modulates Some Metastasis-Related Proteins with Lectin Like Properties in Pancreatic Ductal Adenocarcinoma

dc.contributor.authorSagini, Micah N
dc.contributor.authorKlika, Karel D
dc.contributor.authorOrry, Andrew
dc.contributor.authorZepp, Michael
dc.contributor.authorMutiso, Joshua
dc.contributor.authorBerger, Martin R
dc.date.accessioned2023-07-06T12:24:05Z
dc.date.available2023-07-06T12:24:05Z
dc.date.issued2020
dc.descriptionArticleen_US
dc.description.abstracttermed lactosyl-sepharose binding proteins (LSBPs). The role of these proteins in cancer progression was investigated at mRNA level using chip array data of Suit2-007 and ASML cells re-isolated from nude rats. These data compared significant mRNA expression changes when relating primary (pancreas) and metastatic (liver) sites following orthotopic and intraportal implantation of Pancreatic Ductal Adenocarcinoma (PDAC) cells, respectively. The affinity of Rpx to 13 simple sugar structures was modeled by docking experiments, the ranking of which was principally confirmed by NMRspectroscopy. In addition, Rpx and LSBPs were evaluated for anti-proliferative activity and their cellular uptake was assessed by fluorescence microscopy. From 13 monosaccharides evaluated, open-chain rhamnose, β-D-galactose, and α-L-galactopyranose showed the highest affinities for site 1 of Rpx’s B-chain. NMR evaluation yielded a similar ranking, as galactose was among the best binders. Both, Rpx and LSBPs reduced cell proliferation in vitro, but their anti-proliferative effects were decreased by 15–20% in the presence of galactose. The program “Ingenuity Pathway Analysis” identified 2,415 genes showing significantly modulated mRNA expression following exposure of Suit2-007 cells to Rpx in vitro. These genes were then matched to those 1,639 genes, which were significantly modulated in the rat model when comparing primary and metastatic growth of Suit2-007 cells. In this overlap analysis, LSBP genes were considered separately. The potential suitability of Rpx for treating metastatic Suit2-007 PDAC cells was reflected by those genes, which were modulated by Rpx in a way opposite to that observed in cancer progression. Remarkably, these were 14% of all genes modulated during cancer progression, but 71% of the respective LSBP gene subgroup. Based on these findings, we predict that Rpx has the potential to treat PDAC metastasis by modulating genes involved in metastatic progression, especially by targeting LSBPsen_US
dc.description.sponsorshipThe Ministry of Higher Education, Science and Technology Kenya/NACOSTI)/German Academic Exchange Service scholarship award (MSN).en_US
dc.identifier.citationSagini, M. N., Klika, K. D., Orry, A., Zepp, M., Mutiso, J., & Berger, M. R. (2020). Riproximin exhibits diversity in sugar binding, and modulates some metastasis-related proteins with lectin like properties in pancreatic ductal adenocarcinoma. Frontiers in pharmacology, 11, 549804.en_US
dc.identifier.other| https://doi.org/10.3389/fphar.2020.549804
dc.identifier.urihttp://ir-library.ku.ac.ke/handle/123456789/26108
dc.language.isoenen_US
dc.publisherFrontiers Media SAen_US
dc.subjectPancreatic ductal adenocarcinomaen_US
dc.subjectlactosyl-sepharose binding proteinsen_US
dc.subjectcellular lectinsen_US
dc.subjectribosomeinactivating proteinen_US
dc.subjectmonosaccharidesen_US
dc.subjectaffinityen_US
dc.titleRiproximin Exhibits Diversity in Sugar Binding, and Modulates Some Metastasis-Related Proteins with Lectin Like Properties in Pancreatic Ductal Adenocarcinomaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Riproximin Exhibits Diversity in Sugar Binding, and Modulates Some Metastasis-Related Proteins with Lectin Like Properties in Pancreatic Ductal Adenocarcinoma.pdf
Size:
3.67 MB
Format:
Adobe Portable Document Format
Description:
Full text Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: